BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 15761961)

  • 1. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
    Skrzydlewska E; Sulkowska M; Koda M; Sulkowski S
    World J Gastroenterol; 2005 Mar; 11(9):1251-66. PubMed ID: 15761961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases and the gut barrier.
    Biancheri P; Di Sabatino A; Corazza GR; MacDonald TT
    Cell Tissue Res; 2013 Feb; 351(2):269-80. PubMed ID: 22427120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro invasion assays.
    Chambers SK
    Methods Mol Med; 2001; 39():179-85. PubMed ID: 21340770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.
    Mai J; Waisman DM; Sloane BF
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):215-30. PubMed ID: 10708859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation and cancer.
    Danø K; Behrendt N; Høyer-Hansen G; Johnsen M; Lund LR; Ploug M; Rømer J
    Thromb Haemost; 2005 Apr; 93(4):676-81. PubMed ID: 15841311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
    Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe.
    Greco MR; Antelmi E; Busco G; Guerra L; Rubino R; Casavola V; Reshkin SJ; Cardone RA
    Oncol Rep; 2014 Feb; 31(2):940-6. PubMed ID: 24337203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineating protease functions during cancer development.
    Affara NI; Andreu P; Coussens LM
    Methods Mol Biol; 2009; 539():1-32. PubMed ID: 19377975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrins in regulating proteases to mediate extracellular matrix remodeling.
    Yue J; Zhang K; Chen J
    Cancer Microenviron; 2012 Dec; 5(3):275-83. PubMed ID: 22437309
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    da Silva LB; Menezes MC; Kitano ES; Oliveira AK; Abreu AG; Souza GO; Heinemann MB; Isaac L; Fraga TR; Serrano SMT; Barbosa AS
    Front Cell Infect Microbiol; 2018; 8():92. PubMed ID: 29637048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis.
    Schnaper HW
    Pediatr Nephrol; 1995 Feb; 9(1):104-11. PubMed ID: 7742207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted proteases. Regulation of their activity and their possible role in metastasis.
    Goldberg GI; Frisch SM; He C; Wilhelm SM; Reich R; Collier IE
    Ann N Y Acad Sci; 1990; 580():375-84. PubMed ID: 2159752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration.
    Wolf K; Friedl P
    Trends Cell Biol; 2011 Dec; 21(12):736-44. PubMed ID: 22036198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lysine antifibrinolytics and cyclooxygenase inhibitors on the proteolytic profile of breast cancer cells interacting with macrophages or endothelial cells.
    Afsharimani B; Cabot PJ; Parat MO
    Br J Anaesth; 2014 Jul; 113 Suppl 1():i22-31. PubMed ID: 24418973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis].
    Mohamed-Ali H
    Wien Med Wochenschr; 1991; 141(4):77-85. PubMed ID: 1645488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activation of proteases in co-cultures.
    Paduch R; Kandefer-Szerszeń M
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.